Orlando, Florida


Email Staff Writer Staff Writer on LinkedIn Staff Writer on Twitter Staff Writer on Facebook
Staff Writer
Staff Writer
Contributor •

Bayer's Tardy Report to FDA

Comments Off

Bayer AG has failed to disclose to regulators potentially serious safety concerns about its antibleeding drug Trasylol. The FDA has disclosed that preliminary test results indicate that the drug may cause serious kidney damage, congestive heart failure and strokes and an increased risk of death.